{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:29:49Z","timestamp":1787027389880,"version":"build-2736575974"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>Plasmablastic lymphoma (PBL) is a rare form of lymphoma in people. PBL originates from plasmablasts and usually presents with swelling\/mass in the mouth\/neck. A 7-year-old Mongrel dog was presented for a large oral and neck mass. Cytology and histopathology were suggestive of a round cell tumor that was suspected to be lymphoma. An immunohistochemical (IHC) stain panel showed positive for CD18, thus supporting the diagnosis of round cell tumor, but negative for T- and B-cell lymphomas, CD3, CD20, and PAX-5. Other markers including cytokeratin AE1\/3 (for epithelial cell origin), CD31 (for endothelial cells), SOX10 (for melanoma), IBa-1 (for histiocytic sarcoma), and CD117 (for mast cell tumor) were all negative. MUM-1 (for plasma cell differentiation) was strongly positive and CD79a (B cell and plasma cells) was also scantly positive. Based on the histopathology and immunohistochemistry results in combination with the clinical presentation, a suspected diagnosis of PBL was made. As per available literature, this is perhaps the first highly suspected case of PBL in a dog.<\/jats:p>","DOI":"10.3389\/fvets.2023.1100942","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T06:50:22Z","timestamp":1676530222000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report: Suspected plasmablastic lymphoma in a dog resembling the clinical presentation in humans"],"prefix":"10.3389","volume":"10","author":[{"given":"Antonio","family":"Giuliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sin Yan","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayra C.","family":"Flecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo S.","family":"Horta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-0859-2_16","article-title":"Plasmablastic Lymphoma","author":"Wang","year":"2014","journal-title":"Cancers in People with HIV and AIDS: Progress and Challenges."},{"key":"B2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00277-008-0601-x","article-title":"Plasmablastic Lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome","volume":"88","author":"Ustun","year":"2009","journal-title":"Ann Hematol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.3109\/10428194.2010.516040","article-title":"Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma","volume":"51","author":"Castillo","year":"2010","journal-title":"Leuk Lymphoma."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/annonc\/mdh399","article-title":"CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients","volume":"15","author":"Teruya-Feldstein","year":"2004","journal-title":"Ann Oncol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/j.pathol.2018.12.016","article-title":"The revised who classification of lymphomas \u2013 what has changed for the pathologist and clinician","volume":"51","author":"Jaffe","year":"2019","journal-title":"Pathology."},{"key":"B6","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/modpathol.3800355","article-title":"Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles","volume":"18","author":"Chang","year":"2005","journal-title":"Mod Pathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood."},{"key":"B8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1634\/theoncologist.2009-0304","article-title":"Prognostic factors in chemotherapy-treated patients with HIV-associated plasmablastic lymphoma","volume":"15","author":"Castillo","year":"2010","journal-title":"Oncologist."},{"key":"B9","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/ajh.21250","article-title":"HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases","volume":"83","author":"Castillo","year":"2008","journal-title":"Am J Hematol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/0300985810379428","article-title":"Classification of canine malignant lymphomas according to the world health organization criteria","volume":"48","author":"Valli","year":"2011","journal-title":"Vet Pathol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1590\/1678-4162-11484","article-title":"Caracteriza\u00e7\u00e3ohistopatol\u00f3gica e imunofenot\u00edpica do linfomamultic\u00eantricocanino no Brasil: um estudo de 203 casos","volume":"72","author":"Jark","year":"2020","journal-title":"Arq Bras Med Vet e Zoot."},{"key":"B12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/vetsci8120317","article-title":"Non Epitheliotropic B-cell lymphoma with plasmablastic differentiation vs. cutaneous plasmacytosis in a 12-years-old beagle: case presentation and clinical review","volume":"8","author":"Antognoni","year":"2021","journal-title":"Vet Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1939-165X.2008.00067.x","article-title":"B-cell intestinal lymphoma with Mott cell differ-entiation in a 1-year-old miniature dachshund","volume":"37","author":"Kodama","year":"2008","journal-title":"Vet Clin Pathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1939-165X.2008.00101.x","article-title":"B-cell lymphoma with Mott cell differentiation in two young adult dogs","volume":"38","author":"Stacy","year":"2009","journal-title":"Vet Clin Pathol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.2460\/javma.239.11.1477","article-title":"Monoclonal immunoglobulin proteinproduction in twodogs with secretory B-cell lymphoma with Mott cell differentiation","volume":"239","author":"Seelig","year":"2011","journal-title":"J Am Vet Med Assoc."},{"key":"B16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1177\/104063870902100521","article-title":"Gastric B-cell lymphoma with Mott cell differentiation in a dog","volume":"21","author":"De Zan","year":"2009","journal-title":"J Vet Diagn Invest."},{"key":"B17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jcpa.2012.08.002","article-title":"rare variant of multicentric large B-cell lymphoma with plasmacytoid and mott cell differentiation in a dog","volume":"148","author":"Snyman","year":"2013","journal-title":"J Comp Pathol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1177\/1040638719882045","article-title":"Plasma cell leukemia with plasmablastic morphology in a dog","volume":"31","author":"Dagher","year":"2019","journal-title":"J Vet Diagn Invest."},{"key":"B19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.anndiagpath.2018.09.014","article-title":"Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues","volume":"38","author":"Grimm","year":"2019","journal-title":"Ann Diagn Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/j.1440-1827.2009.02448.x","article-title":"Frequent downregulation or loss of CD79a expression in plasma cell myelomas: potential clue for diagnosis","volume":"59","author":"Tanaka","year":"2009","journal-title":"Pathol Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jaip.2014.03.006","article-title":"Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications","volume":"2","author":"Czarnowicki","year":"2014","journal-title":"J Allergy Clin Immunol Pract."},{"key":"B22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/biology11010054","article-title":"Companion animal model in translational oncology; feline oral squamous cell carcinoma and canine oral melanoma","volume":"11","author":"Giuliano","year":"2021","journal-title":"Biology (Basel)."},{"key":"B23","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.vetimm.2014.02.016","article-title":"Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applications","volume":"159","author":"Ito","year":"2014","journal-title":"Vet Immunol Immunopathol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrc2273","article-title":"Translation of new cancer treatments from pet dogs to humans","volume":"8","author":"Paoloni","year":"2008","journal-title":"Nat Rev Cancer."}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2023.1100942\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T06:50:24Z","timestamp":1676530224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2023.1100942\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":24,"alternative-id":["10.3389\/fvets.2023.1100942"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2023.1100942","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"article-number":"1100942"}}